Belgium advises women to have PIP breast implants removed

February 1, 2012

Belgium's health authorities on Wednesday advised women with defective breast implants made by French firm PIP to have them removed.

Citing an "abnormal risk of rupture," Health Minister Laurette Onkelinx recommended the "removal within a reasonable timeframe, without urgency" of the implants.

Belgian authorities had up to now only recommended that women get check-ups, ask their doctor to remove the implants made by Poly Implant Prothese (PIP) if there were any signs of seepage or rupture.

At least 674 have been fitted in women in Belgium.

Women who refuse to have the implants removed should get MRI exams every six months, Onkelinx and the Superior Health Council advised.

More than 400,000 women around the world are thought to have received implants made by PIP, which shut in 2010 after it was found to have used substandard, industrial-grade .

France vowed Wednesday to strengthen the regulation and monitoring of prosthetics and called for Europe-wide controls in the wake of the global health scare.

Related Stories

Italy seeking women with French breast implants

December 22, 2011

(AP) -- Italy's health ministry on Thursday asked hospitals to track down women who received silicone breast implants made by a suspect French company due to concerns the implants may be unsafe.

Australia: No higher risk from French implants

January 5, 2012

(AP) -- Australian health officials said they have found no evidence that potentially faulty French-made breast implants are at an increased risk of rupture in Australian women.

Dutch women reimbursed for breast implant removals

January 26, 2012

Dutch women wanting to replace potentially defective breast implants made by now-defunct French company PIP will be paid back in full, the Dutch health insurance federation said Thursday.

Recommended for you

Sustaining biomedical research: Med school deans speak out

May 27, 2015

Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine, according to leaders of the nation's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.